Showing results (31-40 of 45) with videos related to

Sort By:
Pageof 5
Journal of Clinical and Experimental Hematopathology : JCEH|December 14, 2018
Potential anti-lymphoma effect of M-CSFR inhibitor in adult T-cell leukemia/lymphomaYoshihiro Komohara, Osamu Noyori, Yoichi Saito, et al.
Clinical & Translational Immunology|August 17, 2019
Expression of IL-34 correlates with macrophage infiltration and prognosis of diffuse large B-cell lymphomaOsamu Noyori, Yoshihiro Komohara, Hesham Nasser, et al.
Molecular and Cellular Biology|March 16, 2005
Potential autoregulation of transcription factor PU.1 by an upstream regulatory elementYutaka Okuno, Gang Huang, Frank Rosenbauer, et al.
Cancer Science|March 28, 2022
Blocking cholesterol efflux mechanism is a potential target for antilymphoma therapyHiromu Yano, Yukio Fujiwara, Hasita Horlad, et al.
Blood|December 6, 2012
PU.1 is a potent tumor suppressor in classical Hodgkin lymphoma cellsHiromichi Yuki, Shikiko Ueno, Hiro Tatetsu, et al.
International Journal of Oncology|December 23, 2014
Shikonin, dually functions as a proteasome inhibitor and a necroptosis inducer in multiple myeloma cellsNaoko Wada, Yawara Kawano, Shiho Fujiwara, et al.
Journal of Clinical and Experimental Hematopathology : JCEH|April 20, 2017
Cell adhesion molecule-1 (CADM1) expressed on adult T-cell leukemia/lymphoma cells is not involved in the interaction with macrophagesYoshihiro Komohara, Chaoya Ma, Hiromu Yano, et al.
The Journal of Investigative Dermatology|June 4, 2018
Differential Roles of Rad18 and Chk2 in Genome Maintenance and Skin Carcinogenesis Following UV ExposureYuki Tanoue, Takeshi Toyoda, Jinghua Sun, et al.
Pageof 5